1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Antibody and Recombinant Protein CDMO Market Size 2018-2029 2.1.2 Antibody and Recombinant Protein CDMO Market Size CAGR by Region 2018 VS 2022 VS 2029 2.2 Antibody and Recombinant Protein CDMO Segment by Type 2.2.1 Antibody CDMO 2.2.2 Recombinant Protein CDMO 2.3 Antibody and Recombinant Protein CDMO Market Size by Type 2.3.1 Antibody and Recombinant Protein CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029) 2.3.2 Global Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2018-2023) 2.4 Antibody and Recombinant Protein CDMO Segment by Application 2.4.1 Pharmaceutical Company 2.4.2 Biotechnology Company 2.4.3 Generic Company 2.5 Antibody and Recombinant Protein CDMO Market Size by Application 2.5.1 Antibody and Recombinant Protein CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029) 2.5.2 Global Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2018-2023) 3 Antibody and Recombinant Protein CDMO Market Size by Player 3.1 Antibody and Recombinant Protein CDMO Market Size Market Share by Players 3.1.1 Global Antibody and Recombinant Protein CDMO Revenue by Players (2018-2023) 3.1.2 Global Antibody and Recombinant Protein CDMO Revenue Market Share by Players (2018-2023) 3.2 Global Antibody and Recombinant Protein CDMO Key Players Head office and Products Offered 3.3 Market Concentration Rate Analysis 3.3.1 Competition Landscape Analysis 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) 3.4 New Products and Potential Entrants 3.5 Mergers & Acquisitions, Expansion 4 Antibody and Recombinant Protein CDMO by Regions 4.1 Antibody and Recombinant Protein CDMO Market Size by Regions (2018-2023) 4.2 Americas Antibody and Recombinant Protein CDMO Market Size Growth (2018-2023) 4.3 APAC Antibody and Recombinant Protein CDMO Market Size Growth (2018-2023) 4.4 Europe Antibody and Recombinant Protein CDMO Market Size Growth (2018-2023) 4.5 Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Growth (2018-2023) 5 Americas 5.1 Americas Antibody and Recombinant Protein CDMO Market Size by Country (2018-2023) 5.2 Americas Antibody and Recombinant Protein CDMO Market Size by Type (2018-2023) 5.3 Americas Antibody and Recombinant Protein CDMO Market Size by Application (2018-2023) 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Antibody and Recombinant Protein CDMO Market Size by Region (2018-2023) 6.2 APAC Antibody and Recombinant Protein CDMO Market Size by Type (2018-2023) 6.3 APAC Antibody and Recombinant Protein CDMO Market Size by Application (2018-2023) 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Antibody and Recombinant Protein CDMO by Country (2018-2023) 7.2 Europe Antibody and Recombinant Protein CDMO Market Size by Type (2018-2023) 7.3 Europe Antibody and Recombinant Protein CDMO Market Size by Application (2018-2023) 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Antibody and Recombinant Protein CDMO by Region (2018-2023) 8.2 Middle East & Africa Antibody and Recombinant Protein CDMO Market Size by Type (2018-2023) 8.3 Middle East & Africa Antibody and Recombinant Protein CDMO Market Size by Application (2018-2023) 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Global Antibody and Recombinant Protein CDMO Market Forecast 10.1 Global Antibody and Recombinant Protein CDMO Forecast by Regions (2024-2029) 10.1.1 Global Antibody and Recombinant Protein CDMO Forecast by Regions (2024-2029) 10.1.2 Americas Antibody and Recombinant Protein CDMO Forecast 10.1.3 APAC Antibody and Recombinant Protein CDMO Forecast 10.1.4 Europe Antibody and Recombinant Protein CDMO Forecast 10.1.5 Middle East & Africa Antibody and Recombinant Protein CDMO Forecast 10.2 Americas Antibody and Recombinant Protein CDMO Forecast by Country (2024-2029) 10.2.1 United States Antibody and Recombinant Protein CDMO Market Forecast 10.2.2 Canada Antibody and Recombinant Protein CDMO Market Forecast 10.2.3 Mexico Antibody and Recombinant Protein CDMO Market Forecast 10.2.4 Brazil Antibody and Recombinant Protein CDMO Market Forecast 10.3 APAC Antibody and Recombinant Protein CDMO Forecast by Region (2024-2029) 10.3.1 China Antibody and Recombinant Protein CDMO Market Forecast 10.3.2 Japan Antibody and Recombinant Protein CDMO Market Forecast 10.3.3 Korea Antibody and Recombinant Protein CDMO Market Forecast 10.3.4 Southeast Asia Antibody and Recombinant Protein CDMO Market Forecast 10.3.5 India Antibody and Recombinant Protein CDMO Market Forecast 10.3.6 Australia Antibody and Recombinant Protein CDMO Market Forecast 10.4 Europe Antibody and Recombinant Protein CDMO Forecast by Country (2024-2029) 10.4.1 Germany Antibody and Recombinant Protein CDMO Market Forecast 10.4.2 France Antibody and Recombinant Protein CDMO Market Forecast 10.4.3 UK Antibody and Recombinant Protein CDMO Market Forecast 10.4.4 Italy Antibody and Recombinant Protein CDMO Market Forecast 10.4.5 Russia Antibody and Recombinant Protein CDMO Market Forecast 10.5 Middle East & Africa Antibody and Recombinant Protein CDMO Forecast by Region (2024-2029) 10.5.1 Egypt Antibody and Recombinant Protein CDMO Market Forecast 10.5.2 South Africa Antibody and Recombinant Protein CDMO Market Forecast 10.5.3 Israel Antibody and Recombinant Protein CDMO Market Forecast 10.5.4 Turkey Antibody and Recombinant Protein CDMO Market Forecast 10.5.5 GCC Countries Antibody and Recombinant Protein CDMO Market Forecast 10.6 Global Antibody and Recombinant Protein CDMO Forecast by Type (2024-2029) 10.7 Global Antibody and Recombinant Protein CDMO Forecast by Application (2024-2029) 11 Key Players Analysis 11.1 Batavia Biosciences 11.1.1 Batavia Biosciences Company Information 11.1.2 Batavia Biosciences Antibody and Recombinant Protein CDMO Product Offered 11.1.3 Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.1.4 Batavia Biosciences Main Business Overview 11.1.5 Batavia Biosciences Latest Developments 11.2 Grifols 11.2.1 Grifols Company Information 11.2.2 Grifols Antibody and Recombinant Protein CDMO Product Offered 11.2.3 Grifols Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.2.4 Grifols Main Business Overview 11.2.5 Grifols Latest Developments 11.3 Cerbios-Pharma SA 11.3.1 Cerbios-Pharma SA Company Information 11.3.2 Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offered 11.3.3 Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.3.4 Cerbios-Pharma SA Main Business Overview 11.3.5 Cerbios-Pharma SA Latest Developments 11.4 HALIX 11.4.1 HALIX Company Information 11.4.2 HALIX Antibody and Recombinant Protein CDMO Product Offered 11.4.3 HALIX Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.4.4 HALIX Main Business Overview 11.4.5 HALIX Latest Developments 11.5 Biovian Oy 11.5.1 Biovian Oy Company Information 11.5.2 Biovian Oy Antibody and Recombinant Protein CDMO Product Offered 11.5.3 Biovian Oy Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.5.4 Biovian Oy Main Business Overview 11.5.5 Biovian Oy Latest Developments 11.6 Catalent 11.6.1 Catalent Company Information 11.6.2 Catalent Antibody and Recombinant Protein CDMO Product Offered 11.6.3 Catalent Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.6.4 Catalent Main Business Overview 11.6.5 Catalent Latest Developments 11.7 Goodwin Biotechnology 11.7.1 Goodwin Biotechnology Company Information 11.7.2 Goodwin Biotechnology Antibody and Recombinant Protein CDMO Product Offered 11.7.3 Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.7.4 Goodwin Biotechnology Main Business Overview 11.7.5 Goodwin Biotechnology Latest Developments 11.8 Merck 11.8.1 Merck Company Information 11.8.2 Merck Antibody and Recombinant Protein CDMO Product Offered 11.8.3 Merck Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.8.4 Merck Main Business Overview 11.8.5 Merck Latest Developments 11.9 Hangzhou Hs-biopharm 11.9.1 Hangzhou Hs-biopharm Company Information 11.9.2 Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Product Offered 11.9.3 Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.9.4 Hangzhou Hs-biopharm Main Business Overview 11.9.5 Hangzhou Hs-biopharm Latest Developments 11.10 Wuxibiologics 11.10.1 Wuxibiologics Company Information 11.10.2 Wuxibiologics Antibody and Recombinant Protein CDMO Product Offered 11.10.3 Wuxibiologics Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.10.4 Wuxibiologics Main Business Overview 11.10.5 Wuxibiologics Latest Developments 11.11 Bioinnobio 11.11.1 Bioinnobio Company Information 11.11.2 Bioinnobio Antibody and Recombinant Protein CDMO Product Offered 11.11.3 Bioinnobio Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.11.4 Bioinnobio Main Business Overview 11.11.5 Bioinnobio Latest Developments 11.12 Thousand Oaks Biopharmaceuticals 11.12.1 Thousand Oaks Biopharmaceuticals Company Information 11.12.2 Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Product Offered 11.12.3 Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.12.4 Thousand Oaks Biopharmaceuticals Main Business Overview 11.12.5 Thousand Oaks Biopharmaceuticals Latest Developments 11.13 Cerbios-Pharma SA 11.13.1 Cerbios-Pharma SA Company Information 11.13.2 Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offered 11.13.3 Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.13.4 Cerbios-Pharma SA Main Business Overview 11.13.5 Cerbios-Pharma SA Latest Developments 11.14 Eurogentec 11.14.1 Eurogentec Company Information 11.14.2 Eurogentec Antibody and Recombinant Protein CDMO Product Offered 11.14.3 Eurogentec Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.14.4 Eurogentec Main Business Overview 11.14.5 Eurogentec Latest Developments 11.15 HJB 11.15.1 HJB Company Information 11.15.2 HJB Antibody and Recombinant Protein CDMO Product Offered 11.15.3 HJB Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.15.4 HJB Main Business Overview 11.15.5 HJB Latest Developments 11.16 Bibo Pharma 11.16.1 Bibo Pharma Company Information 11.16.2 Bibo Pharma Antibody and Recombinant Protein CDMO Product Offered 11.16.3 Bibo Pharma Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.16.4 Bibo Pharma Main Business Overview 11.16.5 Bibo Pharma Latest Developments 11.17 MabPlex International 11.17.1 MabPlex International Company Information 11.17.2 MabPlex International Antibody and Recombinant Protein CDMO Product Offered 11.17.3 MabPlex International Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.17.4 MabPlex International Main Business Overview 11.17.5 MabPlex International Latest Developments 11.18 Genscriptprobio 11.18.1 Genscriptprobio Company Information 11.18.2 Genscriptprobio Antibody and Recombinant Protein CDMO Product Offered 11.18.3 Genscriptprobio Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.18.4 Genscriptprobio Main Business Overview 11.18.5 Genscriptprobio Latest Developments 11.19 Vetter 11.19.1 Vetter Company Information 11.19.2 Vetter Antibody and Recombinant Protein CDMO Product Offered 11.19.3 Vetter Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.19.4 Vetter Main Business Overview 11.19.5 Vetter Latest Developments 11.20 Etinpro (Beijing) Co 11.20.1 Etinpro (Beijing) Co Company Information 11.20.2 Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Product Offered 11.20.3 Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.20.4 Etinpro (Beijing) Co Main Business Overview 11.20.5 Etinpro (Beijing) Co Latest Developments 11.21 Boehringer Ingelheim BioXcellence 11.21.1 Boehringer Ingelheim BioXcellence Company Information 11.21.2 Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Product Offered 11.21.3 Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.21.4 Boehringer Ingelheim BioXcellence Main Business Overview 11.21.5 Boehringer Ingelheim BioXcellence Latest Developments 11.22 Lonza 11.22.1 Lonza Company Information 11.22.2 Lonza Antibody and Recombinant Protein CDMO Product Offered 11.22.3 Lonza Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.22.4 Lonza Main Business Overview 11.22.5 Lonza Latest Developments 11.23 3SBio Inc 11.23.1 3SBio Inc Company Information 11.23.2 3SBio Inc Antibody and Recombinant Protein CDMO Product Offered 11.23.3 3SBio Inc Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.23.4 3SBio Inc Main Business Overview 11.23.5 3SBio Inc Latest Developments 11.24 Porton 11.24.1 Porton Company Information 11.24.2 Porton Antibody and Recombinant Protein CDMO Product Offered 11.24.3 Porton Antibody and Recombinant Protein CDMO Revenue, Gross Margin and Market Share (2018-2023) 11.24.4 Porton Main Business Overview 11.24.5 Porton Latest Developments 12 Research Findings and Conclusion

List of Tables Table 1. Antibody and Recombinant Protein CDMO Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions) Table 2. Major Players of Antibody CDMO Table 3. Major Players of Recombinant Protein CDMO Table 4. Antibody and Recombinant Protein CDMO Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions) Table 5. Global Antibody and Recombinant Protein CDMO Market Size by Type (2018-2023) & ($ Millions) Table 6. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2018-2023) Table 7. Antibody and Recombinant Protein CDMO Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions) Table 8. Global Antibody and Recombinant Protein CDMO Market Size by Application (2018-2023) & ($ Millions) Table 9. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2018-2023) Table 10. Global Antibody and Recombinant Protein CDMO Revenue by Players (2018-2023) & ($ Millions) Table 11. Global Antibody and Recombinant Protein CDMO Revenue Market Share by Player (2018-2023) Table 12. Antibody and Recombinant Protein CDMO Key Players Head office and Products Offered Table 13. Antibody and Recombinant Protein CDMO Concentration Ratio (CR3, CR5 and CR10) & (2021-2023) Table 14. New Products and Potential Entrants Table 15. Mergers & Acquisitions, Expansion Table 16. Global Antibody and Recombinant Protein CDMO Market Size by Regions 2018-2023 & ($ Millions) Table 17. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Regions (2018-2023) Table 18. Global Antibody and Recombinant Protein CDMO Revenue by Country/Region (2018-2023) & ($ millions) Table 19. Global Antibody and Recombinant Protein CDMO Revenue Market Share by Country/Region (2018-2023) Table 20. Americas Antibody and Recombinant Protein CDMO Market Size by Country (2018-2023) & ($ Millions) Table 21. Americas Antibody and Recombinant Protein CDMO Market Size Market Share by Country (2018-2023) Table 22. Americas Antibody and Recombinant Protein CDMO Market Size by Type (2018-2023) & ($ Millions) Table 23. Americas Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2018-2023) Table 24. Americas Antibody and Recombinant Protein CDMO Market Size by Application (2018-2023) & ($ Millions) Table 25. Americas Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2018-2023) Table 26. APAC Antibody and Recombinant Protein CDMO Market Size by Region (2018-2023) & ($ Millions) Table 27. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Region (2018-2023) Table 28. APAC Antibody and Recombinant Protein CDMO Market Size by Type (2018-2023) & ($ Millions) Table 29. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2018-2023) Table 30. APAC Antibody and Recombinant Protein CDMO Market Size by Application (2018-2023) & ($ Millions) Table 31. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2018-2023) Table 32. Europe Antibody and Recombinant Protein CDMO Market Size by Country (2018-2023) & ($ Millions) Table 33. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Country (2018-2023) Table 34. Europe Antibody and Recombinant Protein CDMO Market Size by Type (2018-2023) & ($ Millions) Table 35. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2018-2023) Table 36. Europe Antibody and Recombinant Protein CDMO Market Size by Application (2018-2023) & ($ Millions) Table 37. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2018-2023) Table 38. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size by Region (2018-2023) & ($ Millions) Table 39. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Region (2018-2023) Table 40. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size by Type (2018-2023) & ($ Millions) Table 41. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2018-2023) Table 42. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size by Application (2018-2023) & ($ Millions) Table 43. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2018-2023) Table 44. Key Market Drivers & Growth Opportunities of Antibody and Recombinant Protein CDMO Table 45. Key Market Challenges & Risks of Antibody and Recombinant Protein CDMO Table 46. Key Industry Trends of Antibody and Recombinant Protein CDMO Table 47. Global Antibody and Recombinant Protein CDMO Market Size Forecast by Regions (2024-2029) & ($ Millions) Table 48. Global Antibody and Recombinant Protein CDMO Market Size Market Share Forecast by Regions (2024-2029) Table 49. Global Antibody and Recombinant Protein CDMO Market Size Forecast by Type (2024-2029) & ($ Millions) Table 50. Global Antibody and Recombinant Protein CDMO Market Size Forecast by Application (2024-2029) & ($ Millions) Table 51. Batavia Biosciences Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 52. Batavia Biosciences Antibody and Recombinant Protein CDMO Product Offered Table 53. Batavia Biosciences Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 54. Batavia Biosciences Main Business Table 55. Batavia Biosciences Latest Developments Table 56. Grifols Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 57. Grifols Antibody and Recombinant Protein CDMO Product Offered Table 58. Grifols Main Business Table 59. Grifols Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 60. Grifols Latest Developments Table 61. Cerbios-Pharma SA Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 62. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offered Table 63. Cerbios-Pharma SA Main Business Table 64. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 65. Cerbios-Pharma SA Latest Developments Table 66. HALIX Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 67. HALIX Antibody and Recombinant Protein CDMO Product Offered Table 68. HALIX Main Business Table 69. HALIX Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 70. HALIX Latest Developments Table 71. Biovian Oy Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 72. Biovian Oy Antibody and Recombinant Protein CDMO Product Offered Table 73. Biovian Oy Main Business Table 74. Biovian Oy Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 75. Biovian Oy Latest Developments Table 76. Catalent Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 77. Catalent Antibody and Recombinant Protein CDMO Product Offered Table 78. Catalent Main Business Table 79. Catalent Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 80. Catalent Latest Developments Table 81. Goodwin Biotechnology Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 82. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Product Offered Table 83. Goodwin Biotechnology Main Business Table 84. Goodwin Biotechnology Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 85. Goodwin Biotechnology Latest Developments Table 86. Merck Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 87. Merck Antibody and Recombinant Protein CDMO Product Offered Table 88. Merck Main Business Table 89. Merck Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 90. Merck Latest Developments Table 91. Hangzhou Hs-biopharm Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 92. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Product Offered Table 93. Hangzhou Hs-biopharm Main Business Table 94. Hangzhou Hs-biopharm Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 95. Hangzhou Hs-biopharm Latest Developments Table 96. Wuxibiologics Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 97. Wuxibiologics Antibody and Recombinant Protein CDMO Product Offered Table 98. Wuxibiologics Main Business Table 99. Wuxibiologics Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 100. Wuxibiologics Latest Developments Table 101. Bioinnobio Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 102. Bioinnobio Antibody and Recombinant Protein CDMO Product Offered Table 103. Bioinnobio Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 104. Bioinnobio Main Business Table 105. Bioinnobio Latest Developments Table 106. Thousand Oaks Biopharmaceuticals Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 107. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Product Offered Table 108. Thousand Oaks Biopharmaceuticals Main Business Table 109. Thousand Oaks Biopharmaceuticals Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 110. Thousand Oaks Biopharmaceuticals Latest Developments Table 111. Cerbios-Pharma SA Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 112. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Product Offered Table 113. Cerbios-Pharma SA Main Business Table 114. Cerbios-Pharma SA Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 115. Cerbios-Pharma SA Latest Developments Table 116. Eurogentec Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 117. Eurogentec Antibody and Recombinant Protein CDMO Product Offered Table 118. Eurogentec Main Business Table 119. Eurogentec Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 120. Eurogentec Latest Developments Table 121. HJB Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 122. HJB Antibody and Recombinant Protein CDMO Product Offered Table 123. HJB Main Business Table 124. HJB Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 125. HJB Latest Developments Table 126. Bibo Pharma Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 127. Bibo Pharma Antibody and Recombinant Protein CDMO Product Offered Table 128. Bibo Pharma Main Business Table 129. Bibo Pharma Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 130. Bibo Pharma Latest Developments Table 131. MabPlex International Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 132. MabPlex International Antibody and Recombinant Protein CDMO Product Offered Table 133. MabPlex International Main Business Table 134. MabPlex International Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 135. MabPlex International Latest Developments Table 136. Genscriptprobio Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 137. Genscriptprobio Antibody and Recombinant Protein CDMO Product Offered Table 138. Genscriptprobio Main Business Table 139. Genscriptprobio Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 140. Genscriptprobio Latest Developments Table 141. Vetter Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 142. Vetter Antibody and Recombinant Protein CDMO Product Offered Table 143. Vetter Main Business Table 144. Vetter Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 145. Vetter Latest Developments Table 146. Etinpro (Beijing) Co Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 147. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Product Offered Table 148. Etinpro (Beijing) Co Main Business Table 149. Etinpro (Beijing) Co Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 150. Etinpro (Beijing) Co Latest Developments Table 151. Boehringer Ingelheim BioXcellence Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 152. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Product Offered Table 153. Boehringer Ingelheim BioXcellence Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 154. Boehringer Ingelheim BioXcellence Main Business Table 155. Boehringer Ingelheim BioXcellence Latest Developments Table 156. Lonza Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 157. Lonza Antibody and Recombinant Protein CDMO Product Offered Table 158. Lonza Main Business Table 159. Lonza Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 160. Lonza Latest Developments Table 161. 3SBio Inc Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 162. 3SBio Inc Antibody and Recombinant Protein CDMO Product Offered Table 163. 3SBio Inc Main Business Table 164. 3SBio Inc Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 165. 3SBio Inc Latest Developments Table 166. Porton Details, Company Type, Antibody and Recombinant Protein CDMO Area Served and Its Competitors Table 167. Porton Antibody and Recombinant Protein CDMO Product Offered Table 168. Porton Main Business Table 169. Porton Antibody and Recombinant Protein CDMO Revenue ($ million), Gross Margin and Market Share (2018-2023) Table 170. Porton Latest Developments List of Figures Figure 1. Antibody and Recombinant Protein CDMO Report Years Considered Figure 2. Research Objectives Figure 3. Research Methodology Figure 4. Research Process and Data Source Figure 5. Global Antibody and Recombinant Protein CDMO Market Size Growth Rate 2018-2029 ($ Millions) Figure 6. Antibody and Recombinant Protein CDMO Sales by Geographic Region (2018, 2022 & 2029) & ($ millions) Figure 7. Antibody and Recombinant Protein CDMO Sales Market Share by Country/Region (2022) Figure 8. Antibody and Recombinant Protein CDMO Sales Market Share by Country/Region (2018, 2022 & 2029) Figure 9. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Type in 2022 Figure 10. Antibody and Recombinant Protein CDMO in Pharmaceutical Company Figure 11. Global Antibody and Recombinant Protein CDMO Market: Pharmaceutical Company (2018-2023) & ($ Millions) Figure 12. Antibody and Recombinant Protein CDMO in Biotechnology Company Figure 13. Global Antibody and Recombinant Protein CDMO Market: Biotechnology Company (2018-2023) & ($ Millions) Figure 14. Antibody and Recombinant Protein CDMO in Generic Company Figure 15. Global Antibody and Recombinant Protein CDMO Market: Generic Company (2018-2023) & ($ Millions) Figure 16. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Application in 2022 Figure 17. Global Antibody and Recombinant Protein CDMO Revenue Market Share by Player in 2022 Figure 18. Global Antibody and Recombinant Protein CDMO Market Size Market Share by Regions (2018-2023) Figure 19. Americas Antibody and Recombinant Protein CDMO Market Size 2018-2023 ($ Millions) Figure 20. APAC Antibody and Recombinant Protein CDMO Market Size 2018-2023 ($ Millions) Figure 21. Europe Antibody and Recombinant Protein CDMO Market Size 2018-2023 ($ Millions) Figure 22. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size 2018-2023 ($ Millions) Figure 23. Americas Antibody and Recombinant Protein CDMO Value Market Share by Country in 2022 Figure 24. United States Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 25. Canada Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 26. Mexico Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 27. Brazil Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 28. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Region in 2022 Figure 29. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Type in 2022 Figure 30. APAC Antibody and Recombinant Protein CDMO Market Size Market Share by Application in 2022 Figure 31. China Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 32. Japan Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 33. Korea Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 34. Southeast Asia Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 35. India Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 36. Australia Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 37. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Country in 2022 Figure 38. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2018-2023) Figure 39. Europe Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2018-2023) Figure 40. Germany Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 41. France Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 42. UK Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 43. Italy Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 44. Russia Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 45. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Region (2018-2023) Figure 46. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Type (2018-2023) Figure 47. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size Market Share by Application (2018-2023) Figure 48. Egypt Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 49. South Africa Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 50. Israel Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 51. Turkey Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 52. GCC Country Antibody and Recombinant Protein CDMO Market Size Growth 2018-2023 ($ Millions) Figure 53. Americas Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 54. APAC Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 55. Europe Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 56. Middle East & Africa Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 57. United States Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 58. Canada Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 59. Mexico Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 60. Brazil Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 61. China Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 62. Japan Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 63. Korea Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 64. Southeast Asia Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 65. India Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 66. Australia Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 67. Germany Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 68. France Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 69. UK Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 70. Italy Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 71. Russia Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 72. Spain Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 73. Egypt Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 74. South Africa Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 75. Israel Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 76. Turkey Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 77. GCC Countries Antibody and Recombinant Protein CDMO Market Size 2024-2029 ($ Millions) Figure 78. Global Antibody and Recombinant Protein CDMO Market Size Market Share Forecast by Type (2024-2029) Figure 79. Global Antibody and Recombinant Protein CDMO Market Size Market Share Forecast by Application (2024-2029)